Essayer OR - Gratuit
Making sure APIs made & controlled in consistent way
Ingredients South Asia
|December 1-15, 2025
THERE are a lot of rules, methods, and quality systems that make sure active pharmaceutical ingredients (APIs) are safe, effective, and meet international pharmacopeial and regulatory standards.
These rules are called Current Good Manufacturing Practices (cGMP). Because APIs have a direct impact on the safety and effectiveness of finished medical products given to patients, they need to be closely monitored for quality. APIs are the main active ingredients in pharmaceutical drugs.
An Overview of cGMP and Why It's Important in API Manufacturing:
The idea of "current" is part of cGMP, a new way of thinking about Good Manufacturing Practices (GMP) that focusses on using new technologies, scientific discoveries, and quality risk management methods. The main goal of cGMP is to set up a system that makes sure APIs are made and controlled in a consistent way that meets certain quality standards. This system also lowers the risks of contamination, mix-ups, and deviations during the manufacturing process.
Manufacturing under cGMP conditions covers every important step, from getting and handling raw materials and starting materials to synthesis, isolation, purification, and physical processing, as well as packing, labelling, storing, and shipping. It also includes intermediates and in-process quality control to make sure that the quality and safety profiles stay the same at all times.
Following cGMP makes sure that APIs meet the set standards for identification, purity, strength, and quality. All of these things are important for making sure that patients are safe and that the treatment works. The US Food and Drug Administration (FDA), the European Medicines Agency (EMA), the World Health Organization (WHO), and the International Council for Harmonisation (ICH) have all made cGMP requirements official through guidance documents like ICH Q7, the FDA Code of Federal Regulations (21 CFR parts), and WHO GMP guidelines.
Important Parts of cGMP for APIs
1. Quality Management System (QMS)
Cette histoire est tirée de l'édition December 1-15, 2025 de Ingredients South Asia.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Ingredients South Asia
Ingredients South Asia
With 50.40% in 2024, captive APIs led the market
PHARMACEUTICAL ingredients are mainly divided into two parts i.e. active and inactive pharmaceutical ingredients.
4 mins
December 1-15, 2025
Ingredients South Asia
As mfg evolves, quality control must adapt
IN the pharmaceutical industry, the quality of raw materials especially active pharmaceutical ingredients (APIs) and excipients is what makes medicines safe, effective and trustworthy.
4 mins
December 1-15, 2025
Ingredients South Asia
The unspoken designers of effective drug treatment
Medicine has been related to the active pharmaceutical ingredient (API), the chemical compound that produces therapeutic effect. However, the path between the discovery in a laboratory and a pill in your hand cannot be fully made without excipients.
5 mins
December 1-15, 2025
Ingredients South Asia
Adv fermentation can convert agri waste into cosmetic actives
The natural cosmetics industry is growing at an unprecedented rate. The global market is expected to grow from $52.4 billion in 2025 to $95.7 billion by 2035, which is a strong compound annual growth rate of 5.7%.
4 mins
December 1-15, 2025
Ingredients South Asia
India's cold storage leap: Driving food security
INDIA'S agriculture sector, with a GDP of $262 billion, showcases remarkable resilience, being minimally dependent on imports.
4 mins
December 1-15, 2025
Ingredients South Asia
Transforming India's ingredient mfg landscape
COME December 19-21, 2025, the pharmaceutical world will descend on Bengaluru, not just for another congress, but for a high-stakes convergence of technology, education, and industry - the 74th Indian Pharmaceutical Congress (IPC).
4 mins
December 1-15, 2025
Ingredients South Asia
in-cos attracts celebs at star-studded edition
IN-cosmetics Asia delivered its most influential edition to date. This year's event attracted a star-studded mix of high-profile industry leaders, Csuite executives, celebrity guests, Asian A-listers, beauty entrepreneurs and heads of some of the world's best-known cosmetics houses.
3 mins
December 1-15, 2025
Ingredients South Asia
CMOs optimise supply chain & reduce costs
PHARMACEUTICAL contract manufacturing is when pharmaceutical companies outsource drug production to specialised third-party manufacturers.
4 mins
December 1-15, 2025
Ingredients South Asia
Modular and compact designs are gaining traction
INDIA'S pharmaceutical sector is often referred to as the “pharmacy of the world.” Behind this reputation lies not only drug formulation expertise but also the robust ecosystem of pharma processing machinery manufacturers.
4 mins
December 1-15, 2025
Ingredients South Asia
DGFT resolves concern related to redemption of AAS
IN a significant relief for pharmaceutical exporters, the Directorate General of Foreign Trade (DGFT) has issued a clarification resolving a long-standing concern related to the redemption of Advance Authorisations (AAS) impacted by the erstwhile Rule 96(10) of the CGST Rules-2017.
2 mins
December 1-15, 2025
Listen
Translate
Change font size
